Prostate cancer : translational and emerging therapies /
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
New York :
Informa Healthcare,
[2007]
|
| Series: | Translational medicine ;
1. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- The molecular pathogenesis and pathophysiology of prostate cancer
- Targeted therapies for cancer: definitions and attributes
- Novel biomarkers for disease diagnosis, prognosis, and prediction
- The endothelin pathway and its modulation in prostate cancer
- Targeting extracellular molecules in prostate cancer - mechanisms to inhibit entry into the cell-signaling abyss
- Immunologic approaches to prostate cancer
- Gene therapy and novel clinical trial design
- Angiogenesis inhibitors in prostate cancer
- What antisense oligonucleotides have promise in prostate cancer
- Novel approaches to androgen receptor blockade
- Can post-transcription modifiers change the course of prostate cancer?
- Telomere targeting agents
- Expanding the role of EGFR inhibitors in prostate cancer
- Bone-directed therapy in prostate cancer: rationale and novel approaches
- Inhibiting the proteasome in advanced prostate cancer
- Hsp90: a target for prostate cancer therapy
- Vitamin D analogs and their role in prostate cancer
- Other novel therapies
- Molecular imaging, clinical trial design, and the development of emerging therapies for metastatic prostate cancer.